Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
INLAUDO is a Brazilian healthtech platform for medical imaging centers and clinics, centered on “health + technology + efficiency.” Based on the website, it is not a standalone AI writing tool or general-purpose platform, but rather a digital imaging diagnostics ecosystem built around radiology operations, image storage and distribution, AI-assisted reporting, and accelerated MRI exams.
Its ecosystem includes four product categories: ImagiFlow is an intelligent CRM for radiology, covering sales management, CNES/DataSUS integration, and automated physician revenue sharing; Voxelpacs is a RIS/PACS system for secure storage and efficient distribution of DICOM images; Voxelb.I applies artificial intelligence to imaging reports, aiming to improve productivity and diagnostic accuracy; and Acelerador de RM is designed to reduce MRI exam time by up to 50%, optimizing scheduling and equipment utilization. Overall, it is better suited to healthcare institutions with a certain volume of imaging exams that need to connect business management with imaging workflows.
The page does not disclose public pricing, plans, per-exam billing, or enterprise quote information, nor does it mention any free tier. It only offers a “request a demo” option, so buyers will need to discuss deployment scope, costs, support, and compliance terms with its sales or expert team before purchasing.
Its strengths lie in the breadth of its product line, which can form a closed loop from customer management, RIS/PACS, and DICOM image workflows to AI-assisted reporting. It is also clearly focused on medical imaging, giving it strong vertical relevance. The limitation is the lack of public detail: it does not disclose AI model types, supported disease areas, accuracy metrics, clinical validation, or regulatory certifications, nor does it provide detailed explanations of privacy compliance, data encryption, or access control strategies. Claims such as “improving diagnostic accuracy” and “reducing MRI time by up to 50%” still need to be validated through demos, pilots, and real-world operational data.
INLAUDO is better suited to imaging centers, clinics, and radiology operations teams in Brazil or Portuguese-speaking markets, especially organizations that require CNES/DataSUS integration. The website does not indicate Chinese-language support, RMB payment, or China-local deployment options, and its accessibility from China is unknown. If you are looking for alternatives in China, consider local medical imaging AI vendors such as United Imaging Intelligence, Infervision, and Shukun Technology. International alternatives include Aidoc, Qure.ai, and Rad AI.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on inlaudo.com.br official site.
inlaudo.com.br is an Brazil AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach inlaudo.com.br directly.